- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05160233
Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care (DIGITS)
Digital Treatments for Opioids and Other Substance Use Disorders (DIGITS) in Primary Care: A Hybrid Type-III Implementation Trial
The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. The DIGITS Trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, and Kaiser Permanente Washington, a healthcare delivery system in Washington State.
In this study, the FDA-authorized reSET and reSET-O digital therapeutics will be implemented in Kaiser Permanente Washington primary care clinics. The study will evaluate the extent to which two implementation strategy interventions, health coaching and practice coaching, improve the implementation. Primary care clinics are randomized to receive these implementation strategy interventions. Each clinic will have a 12-month active implementation period beginning on its date of randomization. To study the continued use of reSET and reSET-O after the active implementation period is completed, a sustainment period of up 12 months will follow the active implementation period.
Study Overview
Status
Intervention / Treatment
Detailed Description
Specific Aims of the DIGITS Trial are to:
- Estimate the effect of practice facilitation and health coaching implementation strategies in increasing the reach and fidelity of a digital therapeutic for substance use disorders in primary care clinics.
- Compare the population-level cost-effectiveness of each implementation strategy in increasing reach, fidelity, and abstinence.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tara Beatty, MA
- Phone Number: 206-442-4012
- Email: Tara.C.Beatty@kp.org
Study Contact Backup
- Name: Joseph E Glass, PhD MSW
- Email: joseph.e.glass@kp.org
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98101
- Kaiser Permanente Washington
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Patient Inclusion Criteria:
- Had a primary care visit in a participating clinic during the active implementation period or sustainment period
- Screened positive for substance use on the day of the visit or in the prior year
- Adult aged 18 years or older at time of visit
Clinic Inclusion Criteria:
- At least 1 clinician trained in the use of reSET/reSET-O
Patient Exclusion Criteria:
- Patients who have requested through their health system to opt out of research
Clinic Exclusion Criteria:
- Previously participated in a pilot implementation of reSET/reSET-O
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Implementation
All primary care clinics will implement reSET and reSET-O using standard implementation approach.
|
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
|
Experimental: Standard Implementation Plus Health Coaching
The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.
|
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
The clinic is provided access to a health coach who conducts outreach with patients.
The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.
|
Experimental: Standard Implementation Plus Practice Facilitation
The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and a practice facilitator will provide the clinic with support for implementation.
|
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
A trained facilitator provides support for implementation by delivering the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.
|
Experimental: Standard Implementation Plus Health Coaching and Practice Facilitation
The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.
Additionally, a practice facilitator will provide the clinic with support for implementation.
|
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
The clinic is provided access to a health coach who conducts outreach with patients.
The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.
A trained facilitator provides support for implementation by delivering the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reach of the digital therapeutic to patients in the primary care clinic
Time Frame: 12 months
|
The proportion of patients who initiate the digital therapeutic, defined by instances in which patients open the app, enter the prescription code, and use a treatment module.
|
12 months
|
Fidelity of patients' use of the digital therapeutic to clinical recommendations
Time Frame: 15 months
|
Mean number of weeks during patients' 12-week prescription in which patients use 4 app modules/week and have visited a clinician in the past 30 days
|
15 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Engagement
Time Frame: 15 months
|
Mean number of months in which patients make ≥1 visit for substance use disorder
|
15 months
|
Economic costs
Time Frame: 12 months
|
Costs from the perspective of a health system and payer including implementation, direct intervention, operating, and other indirect health care costs.
This measure will be used to calculate the population-level cost effectiveness of increasing reach, fidelity, and engagement.
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reach-2
Time Frame: 12 months
|
The proportion of patients prescribed reSET or reSET-O
|
12 months
|
Fidelity-2
Time Frame: 15 months
|
Mean number of weeks in which patients use at least 1 module/week
|
15 months
|
Sustainment
Time Frame: 12 months
|
The proportion of patients who are reached during the sustainment period
|
12 months
|
Substance use
Time Frame: Up to 18 months from the patients index visit date
|
The proportion of patients who are reached and reduce their substance use
|
Up to 18 months from the patients index visit date
|
Abstinence
Time Frame: Up to 18 months from the patients index visit date
|
The proportion of patients who are reached and are abstinent from substances
|
Up to 18 months from the patients index visit date
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Joseph E Glass, PhD, MSW, Kaiser Permanente
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1794767
- R01DA047954 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol-Related Disorders
-
National Institute on Alcohol Abuse and Alcoholism...AbbVieCompletedAlcohol Dependence | Alcoholism | Alcohol Use Disorders | Alcohol AbuseUnited States
-
Charles Drew University of Medicine and ScienceWithdrawnAlcohol Drinking | Alcohol Use Disorder | Alcohol Abuse | Alcohol Problem
-
University of New MexicoThe Mind Research NetworkActive, not recruitingAlcohol Drinking | Alcohol Dependence | Alcohol Use Disorder | Alcohol AbuseUnited States
-
Kent State UniversityCompletedAlcohol Use Disorder | Alcohol Abuse | Alcohol Abuse, EpisodicUnited States
-
Karolinska InstitutetCompletedAlcohol Drinking | Alcohol Dependence | Alcohol; Harmful Use | Alcohol Use Disorder | Alcohol AbuseSweden
-
University of Colorado, DenverUnknownAlcohol Use Disorders | Unhealthy Alcohol UseUnited States
-
Boston Medical CenterBoston University; National Institute on Alcohol Abuse and Alcoholism (NIAAA); University of PittsburghCompletedAlcohol Dependence | Alcohol ConsumptionUnited States
-
Boston Medical CenterBoston University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Dependence | Alcohol Abuse | Unhealthy Alcohol Use | Risky Alcohol Consumption Amounts | Hazardous Alcohol UseUnited States
-
National Institute on Alcohol Abuse and Alcoholism...CompletedAlcohol Drinking | Alcoholism | Alcohol Abuse | Alcohol-related DisordersUnited States
-
Queen Mary University of LondonBarts & The London NHS Trust; University of HertfordshireRecruitingAlcohol Use Disorder | Alcohol Abuse or DependenceUnited Kingdom
Clinical Trials on Standard implementation
-
Iowa State UniversityKansas State University; Louisiana State University Health Sciences Center... and other collaboratorsCompletedHealth Promotion | Overweight and Obesity | Sedentary Behavior | Diet, Healthy | Healthy LifestyleUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)Not yet recruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedHuman Immunodeficiency VirusMalawi
-
VA Office of Research and DevelopmentUnknown
-
Yale UniversityNational Institute of Allergy and Infectious Diseases (NIAID); National Heart...CompletedTuberculosis | Tuberculosis, PulmonaryUganda
-
Radboud University Medical CenterUnknown
-
University of FloridaBrooks Rehabilitation; Foundation for Physical Therapy ResearchCompletedLow Back Pain | Neck PainUnited States
-
Dr. Derek ExnerUnknownMyocardial Infarction | Heart Failure | DeathCanada
-
Michigan State UniversityAmerican Cancer Society, Inc.Enrolling by invitationColorectal CancerUnited States